![show business [crossword]](https://snworksceo.imgix.net/bdh/f8d10f54-31a4-4e2a-b1a9-96e7bed087cd.sized-1000x1000.jpg?w=800&fit=crop&ar=16:9&crop=faces,edges#)
Moderna stock nearly doubles on new cancer vaccine results
CNBC’s Annika Kim Constantino reports on Moderna after its experimental skin cancer vaccine with Merck showed success in a late-stage trial.
CNBC’s Annika Kim Constantino reports on Moderna after its experimental skin cancer vaccine with Merck showed success in a late-stage trial.
What's Your Reaction?
